Loading...

Surgical Science Sweden AB (publ)

SUSRF•PNK
HealthcareMedical - Healthcare Information Services
$15.43
$0.45(2.99%)

Surgical Science Sweden AB (publ) (SUSRF) Stock Overview

Explore Surgical Science Sweden AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
0.14%
↑ 0.14%
Profit Growth
$2.58
↓ 43.73%
EPS Growth
$2.58
↓ 43.79%
Operating Margin
15.88%
↓ 23.70%
ROE
2.85%
↓ 43.73%
Dividend Yield
0.00%
Analyst Recommendations data is not available for SUSRFAnalyst Recommendations details for SUSRF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.

CEO

Mr. Tom Englund

Employees

274

Headquarters

Drakegatan 7 A, 3 tr., Gothenburg

Founded

2021

Frequently Asked Questions